DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Papatheodoridis GV, Idilman R, Dalekos GN. , et al.
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

Hepatology 2017;
66 (05) 1444-1453

Download Bibliographical Data

Access:
Access:
Access: